https://regulatorynews.com/korjuny-catumaxomab-ascites-practice-impact Regulatory News en 2026-10-08T11:00:37-04:00 MHRA Approves First Drug for Malignant Ascites https://regulatorynews.com/optune-pax-pancreatic-cancer-practice-impact Regulatory News en 2026-10-08T11:00:37-04:00 TTFields Device Now Part of Pancreatic Cancer Care https://regulatorynews.com/mri2ct-nextmr-spine-fda-clearance Regulatory News en 2026-10-08T09:43:42-04:00 MRI2CT Clears FDA Hurdle for AI Spine Imaging https://regulatorynews.com/novocure-optune-pax-japan-approval Regulatory News en 2026-10-08T09:43:42-04:00 Novocure Wins Japan Approval for Pancreatic Cancer Device https://regulatorynews.com/fda-herpes-claims-warning-letters Regulatory News en 2026-10-08T06:00:05-04:00 FDA Warns Amazon, Walmart Over Herpes Cream Claims https://regulatorynews.com/greenwich-rx-glutathione-recall Regulatory News en 2026-10-08T06:00:05-04:00 FDA Recall: Compounded Glutathione Tied to ED Visits https://regulatorynews.com/mhra-catumaxomab-korjuny-ascites-approval Regulatory News en 2026-10-08T06:00:05-04:00 MHRA Approves Korjuny, a Revived Ascites Antibody https://regulatorynews.com/swiftsight-body-composition-liver-fat-clearance Regulatory News en 2026-10-07T10:51:13-04:00 FDA Clears AI to Quantify Liver, Visceral Fat on MRI https://regulatorynews.com/kymathera-k-1728-series-b-financing Regulatory News en 2026-10-07T09:55:43-04:00 KymaThera Raises $80M to Advance Cancer Drug K-1728 https://regulatorynews.com/seastar-medical-scd-sepsis-breakthrough-designation Regulatory News en 2026-10-07T09:55:43-04:00 SeaStar Earns 7th FDA Breakthrough Device Nod https://regulatorynews.com/tela-bio-liora-monofilament-scaffold-fda-clearance Regulatory News en 2026-10-07T09:55:43-04:00 TELA Bio Wins FDA Clearance for Liora Mesh https://regulatorynews.com/fda-hereditary-cancer-dna-sequencing-classification Regulatory News en 2026-10-07T06:06:00-04:00 FDA Opens a 510(k) Path for Cancer Gene Panels https://regulatorynews.com/fda-ibogaine-trial-design-rfi Regulatory News en 2026-10-07T06:06:00-04:00 FDA Opens Docket on Ibogaine Trial Design, Safety https://regulatorynews.com/mhra-ai-commission-government-response Regulatory News en 2026-10-07T06:06:00-04:00 UK Backs All 44 Recommendations for NHS AI